Provided by Tiger Trade Technology Pte. Ltd.

Quantum Cyber

1.48
-0.0900-5.73%
Post-market: 1.530.0500+3.38%19:48 EDT
Volume:1.56M
Turnover:2.37M
Market Cap:124.42M
PE:-0.71
High:1.60
Open:1.54
Low:1.46
Close:1.57
52wk High:4.93
52wk Low:0.3000
Shares:84.07M
Float Shares:24.34M
Volume Ratio:1.90
T/O Rate:6.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0779
EPS(LYR):-2.7032
ROE:-212.53%
ROA:-64.88%
PB:6.13
PE(LYR):-0.55

Loading ...

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:11 AM

Reuters
·
May 15

Quantum Cyber Launches quantum-cyber.ai Targeting Homeland Security, Autonomous Drone, and Quantum Technology Sectors

GlobeNewswire
·
May 15

Quantum Cyber N.V. Is Building a NextGen Defense Platform, With Former Trump Admin Secretary Now on Board

TIPRANKS
·
May 14

Press Release: Former Trump Administration VA Secretary Peter O'Rourke Sr. Joins Quantum Cyber's Board of Directors

Dow Jones
·
May 14

Cisco, Nokia, Ford, Quantum Cyber And Nebius Group: Why These 5 Stocks Are On Investors' Radars Today

Benzinga_recent_news
·
May 14

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:04 PM

Reuters
·
May 14

Quantum Cyber secures exclusive autonomous drone license

TIPRANKS
·
May 13

Why Is Quantum Cyber Stock (QUCY) Up Today?

TIPRANKS
·
May 13

Press Release: Quantum Cyber N.V. Secures Exclusive Autonomous Drone Platform as Trump Administration Seeks $55 Billion for Drone Warfare

Dow Jones
·
May 13

Quantum Cyber Expands Equity Program and CFO Agreement

TIPRANKS
·
May 09

Mainz Biomed CFO Caragol signs consulting deal with $20,000 monthly retainer

Reuters
·
May 09

Quantum Cyber N.V. completes major financing and governance overhaul

TIPRANKS
·
Apr 29

Mainz Biomed sells unregistered shares in private placement under Securities Act exemption

Reuters
·
Apr 29

Quantum Cyber Divests ColoAlert IP, Refocuses on Pancreatic Screening

TIPRANKS
·
Apr 16

Mainz Biomed agrees to sell next-gen colorectal screening IP for $1.25 million

Reuters
·
Apr 16

Mainz Biomed NV expected to post a loss of $2.80 a share - Earnings Preview

Reuters
·
Apr 01

Mainz Biomed NV expected to post a loss of $2.80 a share - Earnings Preview

Reuters
·
Mar 28

Mainz Biomed falls below Nasdaq $1.00 minimum bid price; compliance period runs through September 16, 2026

Reuters
·
Mar 26

Mainz Biomed targets quantum and cyber defense acquisitions as it aligns strategy with Trump cybersecurity framework

Reuters
·
Mar 17

Quantum Cyber announces stock ticker symbol change

TIPRANKS
·
Mar 13